1.
Baliga BS, Baliga S, Jain A, et al. Digitized smart surveillance and micromanagement using information technology for malaria elimination in Mangaluru, India: an analysis of five-year post-digitization data. Malar J. 2021;20(1):139. Published 2021 Mar 8. doi:10. 1186/s12936-021-03656-8
2.
President’s malaria initiative: malaria operational plan for Kenya 2019. 1-75. https://www.pmi.gov/docs/default-source/default-document-library/ malaria-operational-plans/fy19/fy-2019-kenya-malaria-operational-plan.pdf?sfvrsn=3
3.
Elnour Z, Grethe H, Siddig K, Munga S. Malaria control and elimination in Kenya: economy-wide benefits and regional disparities. Malar J. 2023; 22(1):117. doi:10.1186/s12936-023-04505-6
4.
World Health Organisation: World malaria report 2023.
5.
Korzeniewski K, Bylicka-Szczepanowska E, Lass A. Prevalence of asymptomatic malaria ınfections in seemingly healthy children, the Rural Dzanga Sangha Region, Central African Republic. Int J Environ Res Public Health. 2021;18(2):814. doi:10.3390/ijerph18020814
6.
Kioko CK, Blanford JI. Malaria in Kenya during 2020: malaria indicator survey and suitability mapping for understanding spatial variations in prevalence and risk. GIScience Series. 2023;4:1-5. doi:10.5194/agile-giss- 4-31-2023
7.
Salgado C, Ayodo G, Macklin MD, et al. The prevalence and density of asymptomatic Plasmodium falciparum infections among children and adults in three communities of western Kenya. Malar J. 2021;20(1):371. doi:10.1186/s12936-021-03905-w
8.
Ibrahim AO, Bello IS, Ajetunmobi AO, Ayodapo A, Afolabi BA, Adeniyi MA. Prevalence of asymptomatic malaria infection by microscopy and its determinants among residents of Ido-Ekiti, Southwestern Nigeria. PLoS One. 2023;18(2):e0280981. doi:10.1371/journal.pone.0280981
9.
Nderu D, Kimani F, Thiong’o K, et al. Plasmodium falciparum histidine-rich protein (PfHRP2 and 3) diversity in Western and Coastal Kenya. Sci Rep. 2019;9(1):1709. doi:10.1038/s41598-018-38175-1
10.
Egbewale BE, Akindele AA, Adedokun SA, Oyekale OA. Prevalence of asymptomatic malaria and anemia among elderly population in Osun state, Southwestern Nigeria. Int J Comm Med Public Health. 2018;5(7): 2650-2656. doi:10.18203/2394-6040.ijcmph20182449
11.
WHO Global malaria programme. False-negative RDT results and Plasmodium falciparum histidine-rich protein 2/3 gene deletions. Information Note. 2019;2(1):1-8.
12.
Parsel SM, Gustafson SA, Friedlander E, et al. Malaria over-diagnosis in Cameroon: diagnostic accuracy of fluorescence and staining technologies (FAST) malaria stain and LED microscopy versus Giemsa and bright field microscopy validated by polymerase chain reaction. Infect Dis Poverty. 2017;6(1):32. doi:10.1186/s40249-017-0251-0
13.
Bosco AB, Nankabirwa JI, Yeka A, et al. Limitations of rapid diagnostic tests in malaria surveys in areas with varied transmission intensity in Uganda 2017-2019: Implications for selection and use of HRP2 RDTs. PLoS One. 2020;15(12):e0244457. doi:10.1371/journal.pone.0244457
14.
Kamau E, Yates A, Maisiba R, et al. Epidemiological and clinical implications of asymptomatic malaria and schistosomiasis co-infections in a rural community in western Kenya. BMC Infect Dis. 2021;21(1):937. doi:10.1186/s12879-021-06626-2
15.
Hayuma PM, Wang CW, Liheluka E, et al. Prevalence of asymptomatic malaria, submicroscopic parasitaemia and anaemia in Korogwe District, north-eastern Tanzania. Malar J. 2021;20(1):424. doi:10.1186/s 12936-021-03952-3
16.
USAID, CDC. US President’s malaria initiative Cambodia: malaria operational plan FY 2020. 2020:1-136.
17.
Watson OJ, Sumner KM, Janko M, et al. False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa. BMJ Global Health. 2019;4:e001582. doi: 10.1136/bmjgh-2019-001582
18.
Coldiron ME, Assao B, Langendorf C, et al. Clinical diagnostic evaluation of HRP2 and pLDH-based rapid diagnostic tests for malaria in an area receiving seasonal malaria chemoprevention in Niger. Malar J. 2019;18(1):443. doi:10.1186/s12936-019-3079-1
19.
Cunningham J, Jones S, Gatton ML, et al. A review of the WHO malaria rapid diagnostic test product testing programme (2008-2018): performance, procurement and policy. Malar J. 2019;18(1):387. doi:10. 1186/s12936-019-3028-z
20.
Dalrymple U, Arambepola R, Gething PW, Cameron E. How long do rapid diagnostic tests remain positive after anti-malarial treatment? Malar J. 2018;17(1):228. doi:10.1186/s12936-018-237
21.
Thomson R, Parr JB, Cheng Q, Chenet S, Perkins M, Cunningham J. Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review. Bull World Health Organ. 2020;98(8):558-568. doi:10.2471/BLT.20.250621
22.
Davis EL, Hollingsworth TD, Keeling MJ. An analytically tractable, age-structured model of the impact of vector control on mosquito-transmitted infections. PLoS Comput Biol. 2024;20(3):e1011440. doi:10. 1371/journal.pcbi.1011440
23.
Yang Y, Tang T, Feng B, et al. Disruption of Plasmodium falciparum histidine-rich protein 2 may affect haem metabolism in the blood stage. Parasit Vectors. 2020;13(1):611. doi:10.1186/s13071-020-04460-0
24.
Heinemann M, Phillips RO, Vinnemeier CD, Rolling CC, Tannich E, Rolling T. High prevalence of asymptomatic malaria infections in adults, Ashanti Region, Ghana, 2018. Malar J. 2020;19(1):366. doi:10.1186/ s12936-020-03441-z
25.
Kamau A, Mtanje G, Mataza C, et al. Malaria infection, disease and mortality among children and adults on the coast of Kenya. Malar J. 2020;19(1):210. doi:10.1186/s12936-020-03286-6
26.
Prosser C, Gresty K, Ellis J, et al. Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions in strains from Nigeria, Sudan, and South Sudan. Emerg Infect Dis. 2021;27(2):471-479. doi:10.3201/eid2702.191410
27.
Ntenda PAM, Chirambo AC, Nkoka O, El-Meidany WM, Goupeyou-Youmsi J. Implication of asymptomatic and clinical Plasmodium falciparum infections on biomarkers of iron status among school-aged children in Malawi. Malar J. 2022;21(1):278. doi:10.1186/s12936-022-04297-1
28.
Otambo WO, Onyango PO, Ochwedo K, et al. Clinical malaria incidence and health seeking pattern in geographically heterogeneous landscape of western Kenya. BMC Infect Dis. 2022;22(1):768. doi:10.1186/s12879-022-07757-w
29.
Alemayehu GS, Blackburn K, Lopez K, et al. Detection of high prevalence of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Assosa zone, Ethiopia: implication for malaria diagnosis. Malar J. 2021;20(1):109. doi:10.1186/s12936-021-03629-x
30.
Agaba BB, Yeka A, Nsobya S, et al. Systematic review of the status of pfhrp2 and pfhrp3 gene deletion, approaches and methods used for its estimation and reporting in Plasmodium falciparum populations in Africa: review of published studies 2010-2019. Malar J. 2019;18(1):355. doi:10.1186/s12936-019-2987-4
31.
Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121-126. doi:10.4103/0253-7176.116232
32.
Ochwedo KO, Ariri FO, Otambo WO, et al. Rare alleles and signatures of selection on the immunodominant domains of Pfs230 and Pfs48/45 in malaria parasites from Western Kenya. Front Genet. 2022;13:867906. doi:10.3389/fgene.2022.867906
33.
Bakari C, Jones S, Subramaniam G, et al. Community-based surveys for Plasmodium falciparum Pfhrp2 and Pfhrp3 gene deletions in selected regions of mainland Tanzania. Malar J. 2020;19(1):391. doi:10.1186/s12936-020-03459-3
34.
Plucinski MM, Herman C, Jones S, et al. Screening for Pfhrp2/3-deleted Plasmodium falciparum, non-falciparum, and low-density malaria infections by a multiplex antigen assay. J Infect Dis. 2019;219(3):437-447. doi:10.1093/infdis/jiy525
35.
Ibrahim AO, Bello IS, Ajetunmobi AO, Ayodapo A, Afolabi BA, Adeniyi MA. Prevalence of asymptomatic malaria infection by microscopy and its determinants among residents of Ido-Ekiti, Southwestern Nigeria. PLoS One. 2023;18(2):e0280981. doi:10.1371/journal.pone.0280981
36.
Mensah BA, Myers-Hansen JL, Obeng Amoako E, Opoku M, Abuaku BK, Ghansah A. Prevalence and risk factors associated with asymptomatic malaria among school children: repeated cross-sectional surveys of school children in two ecological zones in Ghana. BMC Public Health. 2021;21(1):1697. doi:10.1186/s12889-021-11714-8
37.
Munde EO, Okeyo WA, Raballah E, et al. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya. BMC Infect Dis. 2017;17(1):289. doi:10.1186/s12879-017-2390-0
38.
Ongonda JK, Ayieko C, Munde E, Miheso S. Effect of rainfall on seasonality of malaria transmission dynamics and percentage occurrence of MRDT positives around the five rural health facilities in Vihiga County, Kenya. IJRIAS. 2024. doi:10.51584/IJRIAS.2024.90347
39.
Sifuna P, Oyugi M, Ogutu B, et al. Health & demographic surveillance system profile: the Kombewa health and demographic surveillance system (Kombewa HDSS). Int J Epidemiol. 2014;43(4):1097-1104. doi:10. 1093/ije/dyu139
</ol>
</div>
<p>